Advanced search
Publication Cover
Cancer Investigation Volume 25, 2007 - Issue 2
Submit an article Journal homepage
108
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Lisa A. Kujawski University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, M.D.,
Walter L. Longo University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, M.D.,
Eliot C. Williams University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, M.D., Ph.D.,
Nancy J. Turman University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, B.S.,
Nancy Brandt University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, R.N., N.P.,
Deane F. Mosher University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, M.D.,
Jens C. Eickhoff University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, Ph.D. &
Brad S. Kahl University of Wisconsin Hospitals and Clinics and University of Wisconsin Comprehensive Cancer Center, Madison WisconsinUSA
, M.D. show all
Pages 87-93 | Published online: 11 Jun 2009

REFERENCES

  • Blum K. A., Lozanski G., Byrd J. C. Adult Burkitt leukemia and lymphoma. Blood 2004; 104: 3009–3020
  • Shiramizu B., et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and EBV association. Blood 1991; 77: 1516–1526
  • Hecht J. L., Aster J. C. Molecular biology of Burkitt's lymphoma. J. Clin. Oncol. 2000; 18: 3707–3721
  • Magrath I. T., Adde M., Shad A., et al. Adults and children with small non cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J. Clin. Oncol. 1996; 14: 925–934
  • Bernstein J. I., Coleman N., Strickler J. G., et al. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non Burkitt's types). J. Clin. Oncol. 1986; 4: 847–858
  • Thomas D. A., Cortes J., O'Brien S., et al. Hyper-CVAD program in Burkitt's type adult acute lymphoblastic leukemia. J. Clin. Oncol. 1999; 17: 2461–2470
  • McMaster M. L., Greer J. P., Greco F. A., et al. Effective treatment of small noncleaved cell lymphoma with high intensity, brief duration chemotherapy. J. Clin. Oncol. 1991; 9: 941–946
  • Lee E. J., Petroni G. R., Schiffer C. A., et al. Brief duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute ALL: results of Cancer and Leukemia Group B Study 9251. J. Clin. Oncol. 2001; 19: 4014–4022
  • Fisher R., et al. Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 1993; 328: 1002–1006
  • Burkitt D. Long term remissions following one and two dose chemotherapy for African lymphoma. Cancer 1967; 20: 756–759
  • Shipp M. A., et al. High dose CHOP as initial therapy for patients with poor prognosis aggressive non-Hodgkin's lymphoma: a dose finding pilot study. J. Clin. Oncol. 1995; 2: 2916–2923
  • LaCasce A., Howard O., Li S., et al. Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with lower toxicity. Leukemia and Lymphoma 2004; 45: 761–767
  • Magrath I. T., et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adult. Blood 1984; 63: 1102–1111
  • Rizzieri D. A., Johnson J. L., Niedzwiecki D., et al. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer 2004; 100: 1438–1448
  • Murphy S. B., Bowman W. P., Abromowitch M., et al. Results of the treatment of advanced-stage Burkitt's lymphoma and B cell (Sig+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J. Clin. Oncol. 1986; 4: 1732–1739
  • Thomas D. A., Cortes J., Faderl S., et al. Hyper-CVAD and rituximab therapy in HIV-negative Burkitt (BL) or Burkitt-like (BLL) leukemia/lymphoma and mature B-cell acute lymphocytic leukemia (B-ALL). Proc. ASCO 2005; 23: 6531a
  • Spreafico F., Massimino M., Luksch R., et al. Intensive, very short -term chemotherapy for advanced Burkitt's lymphoma in children. J. Clin. Oncol. 2002; 20: 2783–2788
  • Mead G. M., Sydes M. R., Walewski J., et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 Study. Ann. Oncol. 2002; 13: 1264–1274

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.